- Home
- DAWN vs WB Comparison
DAWN vs WB Comparison
Compare DAWN & WB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DAWN | WB |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 624.8M | 2.5B |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | DAWN | WB |
|---|---|---|
| Price | $9.91 | $10.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $26.56 | $14.00 |
| AVG Volume (30 Days) | ★ 2.9M | 992.0K |
| Earning Date | 11-04-2025 | 11-18-2025 |
| Dividend Yield | N/A | ★ 16.29% |
| EPS Growth | N/A | ★ 20.16 |
| EPS | N/A | ★ 1.76 |
| Revenue | $133,672,000.00 | ★ $1,740,785,000.00 |
| Revenue This Year | $15.51 | $0.65 |
| Revenue Next Year | $49.99 | $2.27 |
| P/E Ratio | ★ N/A | $5.73 |
| Revenue Growth | ★ 31.11 | N/A |
| 52 Week Low | $5.64 | $7.10 |
| 52 Week High | $13.53 | $12.96 |
Technical Indicators
Market Signals| Indicator | DAWN | WB |
|---|---|---|
| Relative Strength Index (RSI) | 65.37 | 45.96 |
| Support Level | $8.13 | $9.95 |
| Resistance Level | $8.67 | $10.39 |
| Average True Range (ATR) | 0.60 | 0.23 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 81.63 | 40.00 |
Price Performance
Historical ComparisonAbout DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About WB Weibo Corporation
Weibo Corp is a China-based company mainly engaged in the social media advertising business for people to create, discover and distribute content. The company's activities include Advertising and Marketing, which mainly provides a full range of advertising customization and marketing solutions. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The Company's main product is the social platform Weibo.